Multisystem Inflammatory Syndrome in Adults and Severe Toxoplasmosis: Similar Clinical Presentations, Potentially Severe Outcomes.

Ardura, Monica I; Montoya, Jose G; Dyner, LauraLe; Contopoulos-Ioannidis, Despina G.

Afiliação

Ardura MI; Department of Pediatrics, Division of Infectious Diseases and Host Defense Program, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.
Montoya JG; Dr Jack S. Remington Laboratory for Specialty Diagnostics, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto Medical Foundation, Palo Alto, California, USA.
Dyner L; Department of Medical Affairs, Karius Inc, Redwood City, California, USA.
Contopoulos-Ioannidis DG; Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California, USA.

Open Forum Infect Dis ; 9(7): ofac198, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35794941

ABSTRACT

We report a case of a 21-year-old previously healthy man who developed severe toxoplasmosis with chorioretinitis and myositis 2 months after receiving corticosteroids for presumed multisystem inflammatory syndrome in adults, in the setting of a recently acquired acute Toxoplasma infection, likely during a trip to Latin America.

Palavras-chave

COVID-19; multisystem inflammatory syndrome in adults (MIS-A); severe toxoplasmosis

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article